Nuveen Asset Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $571K | Sell |
350,539
-27,104
| -7% | -$44.2K | ﹤0.01% | 2936 |
|
|
2024
Q3 | $1.57M | Sell |
377,643
-64,934
| -15% | -$270K | ﹤0.01% | 2542 |
|
|
2024
Q2 | $2.42M | Sell |
442,577
-112,011
| -20% | -$612K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $5.55M | Sell |
554,588
-173,446
| -24% | -$1.73M | ﹤0.01% | 1933 |
|
|
2023
Q4 | $2.97M | Sell |
728,034
-43,405
| -6% | -$177K | ﹤0.01% | 2228 |
|
|
2023
Q3 | $2.99M | Sell |
771,439
-1,346
| -0.2% | -$5.21K | ﹤0.01% | 2124 |
|
|
2023
Q2 | $4.61M | Sell |
772,785
-7,290
| -0.9% | -$43.4K | ﹤0.01% | 1955 |
|
|
2023
Q1 | $2.55M | Buy |
780,075
+55,450
| +8% | +$181K | ﹤0.01% | 2239 |
|
|
2022
Q4 | $2.86M | Buy |
724,625
+287,018
| +66% | +$1.13M | ﹤0.01% | 2225 |
|
|
2022
Q3 | $2.63M | Sell |
437,607
-167,900
| -28% | -$1.01M | ﹤0.01% | 2260 |
|
|
2022
Q2 | $3.89M | Buy |
605,507
+233,540
| +63% | +$1.5M | ﹤0.01% | 2113 |
|
|
2022
Q1 | $2.55M | Buy |
371,967
+117,788
| +46% | +$808K | ﹤0.01% | 2392 |
|
|
2021
Q4 | $4.06M | Sell |
254,179
-177,405
| -41% | -$2.83M | ﹤0.01% | 2235 |
|
|
2021
Q3 | $10.8M | Buy |
431,584
+128,606
| +42% | +$3.21M | ﹤0.01% | 1725 |
|
|
2021
Q2 | $5.96M | Sell |
302,978
-359,577
| -54% | -$7.07M | ﹤0.01% | 2157 |
|
|
2021
Q1 | $22.2M | Buy |
+662,555
| New | +$22.2M | 0.01% | 1241 |
|